Angiotensin II-induced pulmonary edema in a rabbit model

Japanese Journal of Pharmacology

Volumn 73, Issue 1, 1997, Pages 33-40

  Yamamoto, Takatsugu ^a   Wang, Li Man ^a   Shimakura, Kazuro ^b   Sanaka, Masaki ^a,c   Koike, Yuichi ^a   Mineshita, Satoru ^a  

^a Tokyo Medical and Dental University ^*  (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TEIKYO UNIVERSITY   (Japan)

Author keywords

Afterload; Angiotensin II; Heart failure; Losartan; Pulmonary edema

Indexed keywords

ANGIOTENSIN; LOSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HEART AFTERLOAD; INTRAVENOUS DRUG ADMINISTRATION; LUNG EDEMA; LUNG WEIGHT; MALE; NONHUMAN; RABBIT; SYSTOLIC BLOOD PRESSURE;

EID: 0031058261     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.73.33     Document Type: Article

References (22)

1. Stab NC: Pulmonary edema. Physiol Rev 54 , 678-811 (1974)
2. Shigei T, Sakuma A, Enomoto T, Oh-ishi S and Hatano R: Pulmonary edema induced by adrenaline and related amines in rats, and its modification by various pretreatments. Jpn J Pharmacol 17, 591 -602 (1967)
3. Mineshita S and Shigei T: Prevention of adrenaline-induced pulmonary edema by stem bromelain in rabbits and analysis of the hemodynamic changes. Jpn J Pharmacol 20, 373-382 (1970)
4. Swies J: Haemodynamic changes accompanying lung oedema produced by IV injection of adrenaline or vasopressin into rats. Pol J Pharmacol Pharm 28, 335-340 (1976)
5. Azevedo AD, Cunha-Melo JR and Freire-Maia L: Arterial hypertension and pulmonary edema induced by catecholamines in unanestetized rats. Ital J Pharmacol Soc 11, 157-167 (1979)
6. Kela AK, Krishnan B and Rao AS: Effect of some β-blockers and procaine on adrenaline-induced pulmonary edema and lung surfactant activity in rats. Ind J Physiol Pharmacol 34, 149-151 (1990)
7. Rao VSN and Fonteies MC: Involvement of PAF-acether and eicosanoides in adrenaline-induced pulmonary edema in mice. Braz J Med Biol Res 24, 319-321 (1991)
8. Kramer BL, Massie MB and Topic N: Control trial of captopril in chronic heart failure: a rest and exercise hemodynamic study. Circulation 67, 807-816 (1983)
9. Shimakura K, Sanaka M, Wang L, Mineshita S and Miyazaki M: Pulmonary edema induced by angiotensin II in rats. Jpn J Pharmacol 67, 383-389 (1995)
10. Toda N and Miyazaki M: Regional and species differences in the response of isolated arteries to angiotensin II. Jpn J Pharmacol 28, 495-497 (1978)
11. Healy JK, Elliott AJ and Harrison LC: Effects of angiotensin on plasma electrolyte concentrations in rabbits and in man. Clin Sei Mol Med 46, 19-36 (1974)
12. Gil J and Mcniff JM: Alveolar epithelial lesions induced by angiotensin in rabbit lungs. Am J Physiol 113, 331-340 (1983)
13. Hodge RL, Ng KKF and Vane JR: Disappearance of angiotensin from the circulation of the dog. Nature 215, 138 -141 (1967)
14. Ishikawa N, Kainuma M and Furuta T: Factors influencing fibrin-induced pulmonary edema. Jpn J Pharmacol 46, 255-260 (1988)
15. Kitamura S, Carbini LA, Carretero OA, Simmons WH and Scicli AG: Potentiation by aminopeptidase P of blood pressure response to bradykinin. Br J Pharmacol 114, 6-7 (1995)
16. Ross J Jr: Afterload mismatch and preload reserve: A conceptual framework for the analysis of ventricular function. Prog Cardiovasc Dis 18, 255-264 (1976)
17. Baker KM, Booz GW and Dostal DE: Cardiac actions of angiotensin II: Role of an intracardiac renin-angiotensin system. Am Rev Physiol 54, 227 (1992)
18. Christ DD, Wong PC, Wong YN, Hart SD, Quon CY and Lam ON: The pharmacokinetics and pharmacodynamics of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) in the dog, J Pharmacol Exp Ther 268, 1199-1205 (1994)
19. Lo MW, Goldberg MR, McCrea JB, Lu H, Furtek CI and Bjornsson TD: Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans. Clin Pharmacol Ther 58, 641-649 (1995)
20. Lassegue B: Molecular biology of angiotensin II receptors. In Angiotensin Receptors, Edited by Saavedra JM and Timmermans PBMWM, pp 17-48, Plenum Press, New York (1994)
21. Yukioka T, Yukioka N, Aulick LH, Goodwin CW, Mason AD Jr, Sugimoto T and Pruitt BA Jr: Evaluation of (1-sarcosine, 8-isoleucine) angiotensin II as a therapeutic agent for oleic acid-induced pulmonary edema. Surgery 99, 235-244 (1986)
22. Mookherjee S, Ashutosh K, Smulyan H, Vardan S and Warner R: Arterial oxygenation and pulmonary function with saralasin in chronic lung disease. Chest 83, 842-847 (1983)